Module 4: treatment and care encompass all current recommendations for managing drug-susceptible and drug-resistant TB, alongside patient care and support strategies. Developed according to WHO’s rigorous standards, the guidelines rely on the latest evidence reviews and the GRADE methodology to evaluate evidence quality and determine the strength of each recommendation. Primarily aimed at ...
Cleveland Scene: How To Pass A Hair Follicle Drug Test: The Dos & Don’ts
How To Pass A Hair Follicle Drug Test: The Dos & Don’ts
The use of psychoactive drugs without medical supervision is associated with significant health risks and can lead to the development of drug use disorders. Drug use disorders, particularly when untreated, increase morbidity and mortality risks for individuals, can trigger substantial suffering and lead to impairment in personal, family, social, educational, occupational or other important ...
About WHO Drug Information WHO Drug Information is a quarterly journal providing an overview of topics relating to medicines development and regulation which is targeted to a wide audience of health professionals and policy makers. Launched in 1987, WHO Drug Information communicates the latest international news and trends to regulatory agencies, academic and training institutions, researchers ...
The Unit works globally to improve health and well-being of populations by articulating, promoting, supporting and monitoring evidence-informed policies, strategies and interventions to reduce the burden associated with alcohol, drugs and addictive behaviours.
Other patterns of drug resistance There were an estimated 1.5 million incident cases (95% UI: 0.59–2.4 million) of isoniazid-resistant TB in 2024, including people with both rifampicin-susceptible and rifampicin-resistant TB. Globally in 2024, the estimated proportion of MDR/RR-TB cases with pre-XDR-TB (i.e. resistance to any fluoroquinolone for which testing was done) was 18% (95% UI: 15 ...